Ochman Marek, Galle Dagmara, Kowal Anna, Królikowska Magdalena, Zawadzki Fryderyk, Stanjek-Cichoracka Anita, Łaszewska Anna, Chełmecka Elżbieta, Hrapkowicz Tomasz
Department of Cardiac, Vascular and Endovascular Surgery and Transplantology, Medical University of Silesia in Katowice, 41-800 Zabrze, Poland.
Department of Pulmonology and Internal Medicine, Wielkopolska Centre for Pulmonology and Thoracic Surgery, 60-569 Poznań, Poland.
Viruses. 2025 Mar 19;17(3):438. doi: 10.3390/v17030438.
After transplantation, systematically monitoring and assessing the risk of transplanted organ rejection is crucial. Current methods involving immunosuppressant monitoring, the assessment of organ function, and biopsies are insufficient for predicting rejection. However, regular determination of torque teno virus (TTV) load after transplantation may prove to be a useful parameter for monitoring immunosuppression efficacy. Therefore, we aimed to evaluate TTV load in patients before and after lung transplantation and the kinetics of TTV growth in relation to immunosuppression strength. We included 14 patients (mean age: 49.4 ± 14.0 years) undergoing lung transplantation and determined TTV copy numbers using the commercial ARGENE TTV-R-GENE kit from BioMerieux from the day of transplantation to 180 days post-transplantation. We also developed an empirical immunosuppression unit scale to calculate immunosuppression strength. We observed an average positive correlation between log TTV and immunosuppression strength, with significant increases in log TTV depending on the duration of immunosuppression. These results indicate the potential of TTV as a new parameter to assess the possibility of transplanted organ rejection.
移植后,系统地监测和评估移植器官排斥反应的风险至关重要。目前涉及免疫抑制剂监测、器官功能评估和活检的方法在预测排斥反应方面并不充分。然而,移植后定期测定扭矩病毒(TTV)载量可能是监测免疫抑制效果的一个有用参数。因此,我们旨在评估肺移植患者移植前后的TTV载量以及TTV生长动力学与免疫抑制强度的关系。我们纳入了14例接受肺移植的患者(平均年龄:49.4±14.0岁),并使用生物梅里埃公司的商用ARGENE TTV-R-GENE试剂盒从移植当天到移植后180天测定TTV拷贝数。我们还制定了一个经验性免疫抑制单位量表来计算免疫抑制强度。我们观察到log TTV与免疫抑制强度之间存在平均正相关,log TTV根据免疫抑制持续时间有显著增加。这些结果表明TTV作为评估移植器官排斥可能性的新参数的潜力。